Molecular Partners Ag (MOLN) Receivables (2020 - 2026)
Molecular Partners Ag (MOLN) recorded Receivables of $1.7 million in Q2 2026, down 61.0% from $4.35 million a year earlier and down 42.6% from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2025, Molecular Partners Ag reported Receivables of $2.21 million, down 16.0% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of -6.1% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $2.63 million in FY2024 (+21.1%), $2.17 million in FY2023 (+103.6%), $1.07 million in FY2022 (-96.2%) and $28.07 million in FY2021 (+827.9%).
- The Q2 2026 figure is the lowest quarterly Receivables since Q4 2022.
- On a year-over-year basis, Receivables has declined for five consecutive quarters, with an average decline of 10.8% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 786.4% in Q4 2021, against a decline of 96.2% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.95 million (Q1 2026), $2.29 million (Q4 2025) and $2.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Molecular Partners Ag | 138.65 Mn | -292.59 Mn | - | 1.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.66 Mn |
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 4.52 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 3.95 Mn |
| Jun 30, 2024 | 20.70 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 20.69 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 19.49 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 28.07 Mn |
| Sep 30, 2021 | 5.97 Mn |
API Access
Molecular Partners Ag Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();